Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NovoCure Ltd | 288,517 | reported | 03 Mar 2026 | tx 108+4,734,130−4,386,932 |
| PROKIDNEY CORP. | 135,000 | reported | 28 May 2026 | tx 6+3,400,200 |
| Elanco Animal Health Inc | 94,499 | reported | 29 Nov 2024 | tx 6+94,499 |
| OptiNose, Inc. | 14,439 | reported | 10 Jun 2020 | tx 15+4,563,625−3,245,794 |
| Minerva Neurosciences, Inc. | 2,500 | reported | 10 Jun 2022 | tx 19+228,611 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | GRANT_AWARD | PROKIDNEY CORP. | 135,000 | 0.00 USD | deriv |
| 03 Mar 2026 | GRANT_AWARD | NovoCure Ltd | 200,284 | 0.00 USD | |
| 03 Mar 2026 | SALE | NovoCure Ltd | 21,330 | 13.43 USD | |
| 03 Mar 2026 | SALE | NovoCure Ltd | 50,557 | 12.79 USD | |
| 03 Mar 2026 | GRANT_AWARD | NovoCure Ltd | 200,000 | 0.00 USD | |
| 03 Mar 2026 | GRANT_AWARD | NovoCure Ltd | 30,072 | 0.00 USD | deriv |
| 03 Mar 2026 | GRANT_AWARD | NovoCure Ltd | 258,445 | 0.00 USD | deriv |
| 29 May 2025 | GRANT_AWARD | PROKIDNEY CORP. | 125,862 | 0.00 USD | deriv |
| 29 Nov 2024 | GRANT_AWARD | Elanco Animal Health Inc | 18,169 | 0.00 USD | |
| 30 May 2024 | GRANT_AWARD | PROKIDNEY CORP. | 62,558 | 0.00 USD | deriv |
| 21 May 2024 | PURCHASE | Elanco Animal Health Inc | 15,000 | 16.98 USD | |
| 08 Mar 2024 | PURCHASE | Elanco Animal Health Inc | 15,000 | 16.30 USD | first after silence |
| 30 Nov 2023 | GRANT_AWARD | Elanco Animal Health Inc | 20,374 | 0.00 USD | |
| 29 Jun 2023 | GRANT_AWARD | PROKIDNEY CORP. | 48,128 | 0.00 USD | deriv |
| 30 Nov 2022 | GRANT_AWARD | Elanco Animal Health Inc | 18,649 | 0.00 USD | |
| 02 Aug 2022 | SALE | NovoCure Ltd | 837 | 69.66 USD | |
| 11 Jul 2022 | GRANT_AWARD | PROKIDNEY CORP. | 1,514,326 | 0.00 USD | deriv |
| 11 Jul 2022 | GRANT_AWARD | PROKIDNEY CORP. | 1,514,326 | 0.00 USD | deriv |
| 10 Jun 2022 | GRANT_AWARD | Minerva Neurosciences, Inc. | 2,500 | 0.00 USD | deriv |
| 08 Mar 2022 | SALE | NovoCure Ltd | 2,385 | 70.10 USD | |
| 03 Mar 2022 | GRANT_AWARD | NovoCure Ltd | 14,581 | 80.59 USD | deriv |
| 30 Nov 2021 | GRANT_AWARD | Elanco Animal Health Inc | 7,307 | 0.00 USD | |
| 02 Aug 2021 | SALE | NovoCure Ltd | 995 | 149.38 USD | |
| 11 Jun 2021 | GRANT_AWARD | Minerva Neurosciences, Inc. | 40,000 | 0.00 USD | deriv |
| 13 Apr 2021 | SALE | NovoCure Ltd | 4,338 | 199.71 USD |
1 purchase reported after at least 12 months of silence — most recent on 08 Mar 2024.